These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37878135)

  • 1. Prostate-specific antigen testing rates in high-risk populations: results from the All of Us Research Program.
    Morley F; Iyer HS; Tamimi RM; Nanus DM; Rebbeck TR; Kensler KH
    Cancer Causes Control; 2024 Mar; 35(3):509-521. PubMed ID: 37878135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Access to Prostate-Specific Antigen Testing and Mortality Among Men With Prostate Cancer.
    Iyer HS; Stone BV; Roscoe C; Hsieh MC; Stroup AM; Wiggins CL; Schumacher FR; Gomez SL; Rebbeck TR; Trinh QD
    JAMA Netw Open; 2024 Jun; 7(6):e2414582. PubMed ID: 38833252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-Value Prostate-Specific Antigen Screening in Older Males.
    Kalavacherla S; Riviere P; Javier-DesLoges J; Banegas MP; McKay RR; Murphy JD; Rose BS
    JAMA Netw Open; 2023 Apr; 6(4):e237504. PubMed ID: 37040113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial and Ethnic Variation in PSA Testing and Prostate Cancer Incidence Following the 2012 USPSTF Recommendation.
    Kensler KH; Pernar CH; Mahal BA; Nguyen PL; Trinh QD; Kibel AS; Rebbeck TR
    J Natl Cancer Inst; 2021 Jun; 113(6):719-726. PubMed ID: 33146392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Association of County-level Prostate-specific Antigen Screening with Metastatic Prostate Cancer and Prostate Cancer Mortality.
    Stone BV; Labban M; Beatrici E; Filipas DK; D'Amico AV; Lipsitz SR; Choueiri TK; Kibel AS; Cole AP; Iyer HS; Trinh QD
    Eur Urol Oncol; 2024 Jun; 7(3):563-569. PubMed ID: 38155059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial and Ethnic Disparities in the Use of Prostate Magnetic Resonance Imaging Following an Elevated Prostate-Specific Antigen Test.
    Abashidze N; Stecher C; Rosenkrantz AB; Duszak R; Hughes DR
    JAMA Netw Open; 2021 Nov; 4(11):e2132388. PubMed ID: 34748010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate Cancer Screening Uptake in Transgender Women.
    Kalavacherla S; Riviere P; Kalavacherla S; Anger JT; Murphy JD; Rose BS
    JAMA Netw Open; 2024 Feb; 7(2):e2356088. PubMed ID: 38353948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
    Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
    BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do racial disparities exist in the use of prostate cancer screening and detection tools in veterans?
    Hudson MA; Luo S; Chrusciel T; Yan Y; Grubb RL; Carson K; Scherrer JF
    Urol Oncol; 2014 Jan; 32(1):34.e9-18. PubMed ID: 23506962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disparities Associated with Shared Decision-making in Prostate Cancer Screening.
    Basin MF; Crane K; Basnet A; Chandrasekar T; Shapiro O; Jacob JM; Bratslavsky G; Goldberg H
    Eur Urol Focus; 2023 Nov; 9(6):1008-1015. PubMed ID: 37198068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Prostate-Specific Antigen Screening and Prostate Cancer Mortality Among Non-Hispanic Black and Non-Hispanic White US Veterans.
    Sherer MV; Qiao EM; Kotha NV; Qian AS; Rose BS
    JAMA Oncol; 2022 Oct; 8(10):1471-1476. PubMed ID: 35925581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of Prostate Specific Antigen Screening among Black Men in the United States in the Contemporary Era.
    Sammon JD; Dalela D; Abdollah F; Choueiri TK; Han PK; Hansen M; Nguyen PL; Sood A; Menon M; Trinh QD
    J Urol; 2016 Apr; 195(4 Pt 1):913-8. PubMed ID: 26598427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Prostate-Specific Antigen Screening Rates With Subsequent Metastatic Prostate Cancer Incidence at US Veterans Health Administration Facilities.
    Bryant AK; Lee KM; Alba PR; Murphy JD; Martinez ME; Natarajan L; Green MD; Dess RT; Anglin-Foote TR; Robison B; DuVall SL; Lynch JA; Rose BS
    JAMA Oncol; 2022 Dec; 8(12):1747-1755. PubMed ID: 36279204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations in Age-Adjusted Prostate Cancer Incidence Rates by Race and Ethnicity After Changes in Prostate-Specific Antigen Screening Recommendation.
    Lai SM; Keighley J; Garimella S; Enko M; Parker WP
    JAMA Netw Open; 2022 Nov; 5(11):e2240657. PubMed ID: 36342715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate Cancer Screening and Incidence among Aging Persons Living with HIV.
    Leapman MS; Stone K; Wadia R; Park LS; Gibert CL; Goetz MB; Bedimo R; Rodriguez-Barradas M; Shebl F; Justice AC; Brown ST; Crothers K; Sigel KM
    J Urol; 2022 Feb; 207(2):324-332. PubMed ID: 34555924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate-specific antigen (PSA) screening and follow-up investigations in Māori and non-Māori men in New Zealand.
    Obertová Z; Scott N; Brown C; Hodgson F; Stewart A; Holmes M; Lawrenson R
    BMC Fam Pract; 2014 Aug; 15():145. PubMed ID: 25154420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient perspectives of prostate cancer screening vary by race following 2018 guideline changes.
    Riviere P; Kalavacherla S; Banegas MP; Javier-Desloges J; Martinez ME; Garraway IP; Murphy JD; Rose BS
    Cancer; 2023 Jan; 129(1):82-88. PubMed ID: 36345568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in Prostate-Specific Antigen Testing Relative to the Revised US Preventive Services Task Force Recommendation on Prostate Cancer Screening.
    Leapman MS; Wang R; Park H; Yu JB; Sprenkle PC; Cooperberg MR; Gross CP; Ma X
    JAMA Oncol; 2022 Jan; 8(1):41-47. PubMed ID: 34762100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opportunistic testing versus organized prostate-specific antigen screening: outcome after 18 years in the Göteborg randomized population-based prostate cancer screening trial.
    Arnsrud Godtman R; Holmberg E; Lilja H; Stranne J; Hugosson J
    Eur Urol; 2015 Sep; 68(3):354-60. PubMed ID: 25556937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of Prostate-Specific Antigen (PSA) Testing in the US Population: Results from a National Cross-Sectional Survey.
    Johnson JA; Moser RP; Ellison GL; Martin DN
    J Community Health; 2021 Apr; 46(2):389-398. PubMed ID: 33064229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.